Deals wrap: Genzyme stand-off
Email 
Print
“It is a game of nerves at this point,” said a banker familiar with the Sanofi-Aventis bid for Genzyme. The transatlantic takeover fight descended into an ill-tempered stand-off on Friday over the price of the deal. *View article *View WSJ article *View article on why banks are scrambling to fund Sanofi’s bid
Transatlantic deals this year have been about buying existing products and established brands in the mature markets of the U.S. and Britain. *View article
European banks and insurers will be forced to consolidate in response to new regulations, a top Credit Suisse investment banker told Reuters. *View article
Post Your Comment
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
-
Author Profile
-
